TrialLipids2025

Efficacy and safety of low-dose atorvastatin plus ezetimibe for primary hypercholesterolemia: A randomized, double-blind, multicenter phase 3 trial.

Tae Oh Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.